Impact Biomedical shareholders elect directors, ratify auditor, approve say-on-pay at 2025 annual meeting

IMPACT BIOMEDICAL INC.

All eight director nominees elected with ~61.5M votes each; broker non-votes of ~2.7M.
Ratification of Grassi & Co. as auditor for FY2025 received 64.1M votes for, 174k against.
Advisory say-on-pay approved: 61.5M for, 108k against, 2.7M broker non-votes.
Quorum of 88.5% of outstanding shares (64.3M shares) represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.